Inflexxion, Inc. Offers Analysis of FDA Advisory Committee Meeting on Prescription Opioid Post-Marketing Studies

FDA Advisory Committee seeks new formulations of prescription opioids to decreased capacity for abuse or tampering (PRWeb December 06, 2010) Read the full story at (5 hours ago)

Tags: , , , , , ,